Key facts
- This page summarizes Daron Evans's Form 4 filing for NEPHROS INC (NEPH).
- 4 reported transactions and 8 derivative rows are listed below.
- Accepted by SEC: 25 May 2021, 15:40.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Exercise of in-the-money or at-the-money derivative security
Exercise of in-the-money or at-the-money derivative security
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Exercise of in-the-money or at-the-money derivative security
Exercise of in-the-money or at-the-money derivative security
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The Reporting Person is a managing director of the LLC that owns the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Footnote F2
Fully exercisable.
Footnote F3
On 4/15/15, the Reporting Person was granted an option to purchase 242,690 shares of common stock of the Company. Options to purchase 84,941 shares vest quarterly in 16 equal amounts commencing on 6/30/15; options to purchase 36,404 shares vested on 8/9/19; and options to purchase 121,345 shares vested upon achievement of previously disclosed performance measures.
Footnote F4
On 12/20/17, the Reporting Person was granted an option to purchase 93,014 shares of common stock of the Company. Options to purchase 23,253 shares vested on 12/20/18 and options to purchase 69,761 shares vest quarterly in 12 equal amounts commencing on 3/20/19.
Footnote F5
On 12/16/19, the Reporting Person was granted an option to purchase 20,000 shares of common stock of the Company. Options to purchase 5,000 shares vest on 12/16/20 and options to purchase 15,000 shares vest quarterly in 12 equal amounts commencing on 3/16/21.
Footnote F6
Previous filings mistakenly reflected this amount as 1,112 shares; the correct amount after appropriate rounding adjustments is 1,111 shares, as reflected above.